首页> 美国卫生研究院文献>Drug Delivery >Dual functional matrix metalloproteinase-responsive curcumin-loadednanoparticles for tumor-targeted treatment
【2h】

Dual functional matrix metalloproteinase-responsive curcumin-loadednanoparticles for tumor-targeted treatment

机译:双功能基质金属蛋白酶响应姜黄素加载纳米粒子用于肿瘤靶向治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The limitations of anticancer drugs, including poor tumor targeting and weak uptakeefficiency, are important factors affecting tumor therapy. According to characteristics ofthe tumor microenvironment, in this study, we aimed to synthesize matrix metalloproteinase(MMP)-responsive curcumin (Cur)-loaded nanoparticles (Cur-P-NPs) based on amphiphilicblock copolymer (MePEG-peptide-PET-PCL) with MMP-cleavable peptide (GPLGIAGQ) andpenetrating peptide (r9), modified to improve tumor targeting and cellular uptake. Theaverage size of Cur-P-NPs was 176.9 nm, with a zeta potential of 8.1 mV, and they showeddrug entrapment efficiency and a loading capacity of 87.07% ± 0.63% and 7.44% ± 0.16%,respectively. Furthermore, Cur release from Cur-P-NPs was sustained for 144 h at pH 7.4,and the release rate was accelerated under enzyme reaction condition. The MTT assaydemonstrated that free P-NPs had favorable biosafety, and the anti-proliferative activityof Cur-P-NPs was positively correlated with Cur concentration in MCF-7 cells.Additionally, the results of cellular uptake, in vivo pharmacokinetics, andbiodistribution showed that Cur-P-NPs had a good effect on cellular uptake and tumortargeting, resulting in the best bioavailability in tumor therapy. Therefore, Cur-P-NPs,as a promising drug delivery system, might lead to a new and efficient route for targetedtherapy in clinical practice.
机译:抗癌药的局限性包括不良的肿瘤靶向性和吸收弱效率,是影响肿瘤治疗的重要因素。根据特点肿瘤微环境,在这项研究中,我们旨在合成基质金属蛋白酶(MMP)反应性姜黄素(Cur)负载的基于两亲的纳米颗粒(Cur-P-NPs)嵌段共聚物(MePEG-肽-PET-PCL)与MMP可裂解肽(GPLGIAGQ)和穿透肽(r9),经过修饰可改善肿瘤靶向和细胞摄取。的Cur-P-NP的平均大小为176.9 nm,ζ电位为8.1 mV,它们显示药物截留效率和载量分别为87.07%±0.63%和7.44%±0.16%,分别。此外,在pH 7.4下,Cur-P-NPs的Cur释放持续了144 h,在酶反应条件下,释放速度加快。 MTT分析证明游离P-NP具有良好的生物安全性,并且具有抗增殖活性Cur-P-NPs的表达与MCF-7细胞中的Cur浓度呈正相关。此外,细胞摄取,体内药代动力学和生物分布表明,Cur-P-NPs对细胞摄取和肿瘤有良好的作用靶向,从而在肿瘤治疗中获得最佳的生物利用度。因此,Cur-P-NP作为一种有前途的药物输送系统,可能会为靶向药物的开发带来新的有效途径临床实践中的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号